Diabetic Retinopathy: The Silent Threat to Vision | Golden Age

Diabetic retinopathy, a complication of diabetes, affects over 93 million people worldwide, with 28% of Americans diagnosed with diabetes suffering from some form of the disease. According to the National Eye Institute, the condition is the leading cause of blindness in adults aged 20-74, with a projected 191 million people worldwide to be affected by 2030. The disease is characterized by damage to the blood vessels in the retina, often caused by high blood sugar levels, and can be treated with laser surgery, injections, or vitrectomy. However, controversy surrounds the effectiveness of these treatments, with some studies suggesting that they may not be as effective as previously thought. Researchers like Dr. Lloyd Paul Aiello and Dr. George L. King are working to develop new treatments, including anti-vascular endothelial growth factor (VEGF) therapies. As the global prevalence of diabetes continues to rise, the importance of addressing diabetic retinopathy cannot be overstated, with the World Health Organization estimating that the number of people with diabetes will increase to 578 million by 2030.